These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30697513)

  • 1. A Series of Analogues to the AT
    Isaksson R; Lindman J; Wannberg J; Sallander J; Backlund M; Baraldi D; Widdop R; Hallberg M; Åqvist J; Gutierrez de Teran H; Gising J; Larhed M
    ChemistryOpen; 2019 Jan; 8(1):114-125. PubMed ID: 30697513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-(Methyloxycarbonyl)thiophene sulfonamides as high affinity AT2 receptor ligands.
    Wannberg J; Gising J; Lindman J; Salander J; Gutiérrez-de-Terán H; Ablahad H; Hamid S; Grönbladh A; Spizzo I; Gaspari TA; Widdop RE; Hallberg A; Backlund M; Leśniak A; Hallberg M; Larhed M
    Bioorg Med Chem; 2021 Jan; 29():115859. PubMed ID: 33309749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A convenient transesterification method for synthesis of AT2 receptor ligands with improved stability in human liver microsomes.
    Wannberg J; Isaksson R; Bremberg U; Backlund M; Sävmarker J; Hallberg M; Larhed M
    Bioorg Med Chem Lett; 2018 Feb; 28(3):519-522. PubMed ID: 29279275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II AT2 receptor ligands with phenylthiazole scaffolds.
    Gopalan G; Palo-Nieto C; Petersen NN; Hallberg M; Larhed M
    Bioorg Med Chem; 2022 Jul; 65():116790. PubMed ID: 35550979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(Heteroaryl)thiophene sulfonamides as angiotensin AT2 receptor ligands.
    Wannberg J; Gising J; Henriksson M; Vo DD; Sävmarker J; Sallander J; Gutiérrez-de-Terán H; Larsson J; Hamid S; Ablahad H; Spizzo I; Gaspari TA; Widdop RE; Grönbladh A; Petersen NN; Backlund M; Hallberg M; Larhed M
    Eur J Med Chem; 2024 Feb; 265():116122. PubMed ID: 38199164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative functional properties of two structurally similar selective nonpeptide drug-like ligands for the angiotensin II type-2 (AT(2)) receptor. Effects on neurite outgrowth in NG108-15 cells.
    Guimond MO; Wallinder C; Alterman M; Hallberg A; Gallo-Payet N
    Eur J Pharmacol; 2013 Jan; 699(1-3):160-71. PubMed ID: 23211679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Pro7Ang III is a novel highly selective angiotensin II type 2 receptor (AT2R) agonist, which acts as a vasodepressor agent via the AT2R in conscious spontaneously hypertensive rats.
    Del Borgo M; Wang Y; Bosnyak S; Khan M; Walters P; Spizzo I; Perlmutter P; Hilliard L; Denton K; Aguilar MI; Widdop RE; Jones ES
    Clin Sci (Lond); 2015 Sep; 129(6):505-13. PubMed ID: 26186568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Alkyl substituted benzimidazoles as a new class of selective AT2 receptor ligands.
    Roy T; Petersen NN; Gopalan G; Gising J; Hallberg M; Larhed M
    Bioorg Med Chem; 2022 Jul; 66():116804. PubMed ID: 35576659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin Peptides as AT2 Receptor Agonists.
    Hallberg M; Sävmarker J; Hallberg A
    Curr Protein Pept Sci; 2017; 18(8):809-818. PubMed ID: 28164758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
    Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
    Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using conformational constraints at position 6 of Angiotensin II to generate compounds with enhanced AT2R selectivity and proteolytic stability.
    Tourwé D; Tsiailanis AD; Parisis N; Hirmiz B; Del Borgo M; Aguilar MI; Van der Poorten O; Ballet S; Widdop RE; Tzakos AG
    Bioorg Med Chem Lett; 2021 Jul; 43():128086. PubMed ID: 33965531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Angiotensin AT
    Steckelings UM; Widdop RE; Sturrock ED; Lubbe L; Hussain T; Kaschina E; Unger T; Hallberg A; Carey RM; Sumners C
    Pharmacol Rev; 2022 Oct; 74(4):1051-1135. PubMed ID: 36180112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interconversion of Functional Activity by Minor Structural Alterations in Nonpeptide AT2 Receptor Ligands.
    Wallinder C; Sköld C; Botros M; Guimond MO; Hallberg M; Gallo-Payet N; Karlén A; Alterman M
    ACS Med Chem Lett; 2015 Feb; 6(2):178-82. PubMed ID: 25699147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade.
    Widdop RE; Matrougui K; Levy BI; Henrion D
    Hypertension; 2002 Oct; 40(4):516-20. PubMed ID: 12364356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the Therapeutic Potential of a Bicyclic Hydroxypyridone Compound 2-[(2,4-Dichlorophenyl)methyl]-7-hydroxy-1,2,3,4-tetrahydro-8H-pyrido[1,2-a]pyrazin-8-one as COMT Inhibitor in the Treatment of Parkinson's Disease: A Molecular Dynamic Simulation Approach.
    Subair TI; Akawa OB; Soremekun OS; Olotu FA; Soliman MES
    Chem Biodivers; 2021 Sep; 18(9):e2100204. PubMed ID: 34252268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiotensin AT
    Fredgart MH; Leurgans TM; Stenelo M; Nybo M; Bloksgaard M; Lindblad L; De Mey JGR; Steckelings UM
    Peptides; 2023 Jun; 164():170990. PubMed ID: 36894067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGP42112: the full AT2 receptor agonist and its role in the renin-angiotensin-aldosterone system: no longer misunderstood.
    Restrepo YM; Noto NM; Speth RC
    Clin Sci (Lond); 2022 Nov; 136(21):1513-1533. PubMed ID: 36326719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancer.
    Guimond MO; Battista MC; Nikjouitavabi F; Carmel M; Barres V; Doueik AA; Fazli L; Gleave M; Sabbagh R; Gallo-Payet N
    Prostate; 2013 Jul; 73(10):1057-68. PubMed ID: 23389987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT₂ receptor activation induces natriuresis and lowers blood pressure.
    Kemp BA; Howell NL; Gildea JJ; Keller SR; Padia SH; Carey RM
    Circ Res; 2014 Jul; 115(3):388-99. PubMed ID: 24903104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.